Cyndeo Wealth Partners LLC boosted its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 360.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 56,783 shares of the company’s stock after purchasing an additional 44,464 shares during the period. Cyndeo Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $4,845,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Hanson & Doremus Investment Management increased its position in Colgate-Palmolive by 39.8% in the 3rd quarter. Hanson & Doremus Investment Management now owns 9,256 shares of the company’s stock worth $790,000 after purchasing an additional 2,637 shares during the last quarter. Pension & Wealth Management Advisors Inc. purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $322,000. Howard Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 140.5% during the 3rd quarter. Howard Capital Management LLC now owns 12,062 shares of the company’s stock valued at $1,029,000 after buying an additional 7,047 shares during the last quarter. Annex Advisory Services LLC lifted its holdings in shares of Colgate-Palmolive by 136.1% during the 3rd quarter. Annex Advisory Services LLC now owns 13,604 shares of the company’s stock valued at $1,161,000 after buying an additional 7,843 shares during the last quarter. Finally, NFSG Corp grew its stake in shares of Colgate-Palmolive by 831.3% in the 3rd quarter. NFSG Corp now owns 6,221 shares of the company’s stock valued at $531,000 after buying an additional 5,553 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently commented on CL. UBS Group set a $106.00 price objective on Colgate-Palmolive in a report on Thursday. Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Morgan Stanley reissued an “overweight” rating and issued a $104.00 target price (up from $100.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Finally, BNP Paribas Exane cut their price target on shares of Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating on the stock in a report on Monday, September 28th. Thirteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $97.95.
Read Our Latest Analysis on CL
Insider Buying and Selling at Colgate-Palmolive
In other news, CEO Noel Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the transaction, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares of the company’s stock, valued at $5,974,137.05. The trade was a 13.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 175,191 shares of company stock worth $16,110,903 over the last 90 days. Insiders own 0.43% of the company’s stock.
Colgate-Palmolive Stock Performance
CL opened at $94.02 on Friday. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The company has a market cap of $74.95 billion, a PE ratio of 37.31, a price-to-earnings-growth ratio of 4.43 and a beta of 0.33. The stock has a 50-day moving average of $89.05 and a 200-day moving average of $89.02. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The business had revenue of $5.36 billion for the quarter, compared to the consensus estimate of $5.36 billion. During the same period last year, the business earned $0.92 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.
About Colgate-Palmolive
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
